Vitronectin-based hydrogels recapitulate neuroblastoma growth conditions.

digital image analysis extracellular matrix neuroblastoma polyethylene-glycol stiffness vitronectin

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2022
Historique:
received: 07 07 2022
accepted: 20 09 2022
entrez: 25 11 2022
pubmed: 26 11 2022
medline: 26 11 2022
Statut: epublish

Résumé

The tumor microenvironment plays an important role in cancer development and the use of 3D

Identifiants

pubmed: 36425532
doi: 10.3389/fcell.2022.988699
pii: 988699
pmc: PMC9679952
doi:

Types de publication

Journal Article

Langues

eng

Pagination

988699

Informations de copyright

Copyright © 2022 Monferrer, Dobre, Trujillo, González Oliva, Trubert-Paneli, Acevedo-León, Noguera and Salmeron-Sanchez.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Mol Sci. 2018 Oct 04;19(10):
pubmed: 30287763
Angiogenesis. 2022 Feb;25(1):71-86
pubmed: 34170441
Acta Biomater. 2018 Apr 1;70:120-128
pubmed: 29452274
Biomacromolecules. 2003 May-Jun;4(3):713-22
pubmed: 12741789
Cold Spring Harb Perspect Biol. 2011 Dec 01;3(12):
pubmed: 21917992
Oncotarget. 2015 Sep 8;6(26):22452-66
pubmed: 26084291
ACS Biomater Sci Eng. 2017 Dec 11;3(12):3433-3446
pubmed: 33445382
Sci Rep. 2020 Apr 14;10(1):6370
pubmed: 32286364
Mol Biol Cell. 2016 Nov 1;27(21):3284-3292
pubmed: 27605703
Biofabrication. 2017 Aug 03;9(3):032003
pubmed: 28707624
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3323-8
pubmed: 20080569
Exp Cell Res. 2016 Apr 10;343(1):60-66
pubmed: 26524505
Cancer Cell Int. 2010 Jun 22;10:18
pubmed: 20569458
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11364-71
pubmed: 26617861
Front Oncol. 2014 Mar 04;4:39
pubmed: 24624363
Int J Cancer. 2020 Jan 15;146(2):553-565
pubmed: 31173338
Biomaterials. 2017 Jan;113:170-175
pubmed: 27816000
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1853-8
pubmed: 11172040
Front Cell Dev Biol. 2022 Apr 08;10:818616
pubmed: 35493073
Oncol Rep. 2015 Apr;33(4):1837-43
pubmed: 25634491
Curr Pharm Des. 2009;15(12):1373-84
pubmed: 19355975
Adv Mater. 2012 Jan 3;24(1):64-70, 2
pubmed: 22174081
Matrix Biol Plus. 2022 Mar 21;14:100109
pubmed: 35399702
Acta Biomater. 2011 Jun;7(6):2401-9
pubmed: 21439409
BMC Cancer. 2019 May 22;19(1):479
pubmed: 31117974
Cancer Lett. 2019 Oct 1;461:112-122
pubmed: 31325528
Oncotarget. 2016 Oct 25;7(43):69829-69843
pubmed: 27634880
J Exp Clin Cancer Res. 2020 Oct 28;39(1):226
pubmed: 33109237
Cancer Treat Rev. 2010 Jun;36(4):277-85
pubmed: 20231056
Int J Cancer. 2003 Dec 10;107(5):688-95
pubmed: 14566816
Biomaterials. 2005 May;26(15):2467-77
pubmed: 15585249
Int J Mol Sci. 2020 Nov 17;21(22):
pubmed: 33212997
Biomacromolecules. 2014 Jan 13;15(1):195-205
pubmed: 24274760
Pediatr Blood Cancer. 2017 Sep;64(9):
pubmed: 28121069
Drug Deliv Transl Res. 2015 Apr;5(2):125-36
pubmed: 25787738
Oncotarget. 2018 May 25;9(40):26157-26170
pubmed: 29899849
J Vis Exp. 2022 Jan 18;(179):
pubmed: 35129176
PLoS One. 2017 Jul 27;12(7):e0182039
pubmed: 28750018
Immunology. 2018 Oct;155(2):186-201
pubmed: 29908065
J Cell Biol. 2013 Jun 24;201(7):1069-84
pubmed: 23798731
Histol Histopathol. 2012 Jun;27(6):693-705
pubmed: 22473691
Br J Cancer. 2016 Aug 9;115(4):480-9
pubmed: 27415013
Int J Cell Biol. 2012;2012:219196
pubmed: 22262973
Front Oncol. 2021 Jan 27;10:624079
pubmed: 33585251
Biomaterials. 2016 May;89:136-47
pubmed: 26967648
Oncoimmunology. 2022 May 24;11(1):2075204
pubmed: 35646475
Lancet. 2007 Jun 23;369(9579):2106-20
pubmed: 17586306
Int J Pharm. 2021 Oct 25;608:121058
pubmed: 34461172
J Clin Pathol. 1993 Nov;46(11):1042-5
pubmed: 7504702
PLoS One. 2022 May 26;17(5):e0268300
pubmed: 35617163
Haematologica. 2009 Jan;94(1):16-21
pubmed: 19118376
Biomaterials. 2020 Sep;252:120104
pubmed: 32422492
Mol Ther. 2022 Jul 6;30(7):2554-2567
pubmed: 35358687
J Biomater Sci Polym Ed. 2009;20(12):1763-79
pubmed: 19723440
J Mech Behav Biomed Mater. 2020 Mar;103:103581
pubmed: 32090910
Matrix Biol Plus. 2022 May 16;14:100111
pubmed: 35619988
Acta Biomater. 2014 Mar;10(3):1102-11
pubmed: 24287160
Oncol Rep. 2013 May;29(5):1714-20
pubmed: 23446555
Biomacromolecules. 2015 Aug 10;16(8):2316-26
pubmed: 26098148
FEBS Lett. 1995 Aug 7;369(2-3):249-51
pubmed: 7544295
Nat Cell Biol. 2016 May;18(5):540-8
pubmed: 27065098

Auteurs

Ezequiel Monferrer (E)

Department of Pathology Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, Valencia, Spain.
Low Prevalence Tumors, Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Oana Dobre (O)

Centre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.

Sara Trujillo (S)

INM-Leibniz Institute for New Materials, Saarbrücken, Germany.

Mariana Azevedo González Oliva (MA)

Centre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.

Alexandre Trubert-Paneli (A)

Centre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.

Delia Acevedo-León (D)

Clinical Analysis Service, Hospital Universitario Dr. Peset, Valencia, Spain.

Rosa Noguera (R)

Department of Pathology Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, Valencia, Spain.
Low Prevalence Tumors, Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Manuel Salmeron-Sanchez (M)

Centre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.

Classifications MeSH